BRIEF-Aduro Biotech Presents Nonclinical, Phase 1 Healthy Volunteer Data For BION-1301

2020-06-02 19:39

Aduro Biotech(ADRO) 0

June 2 (Reuters) - Aduro Biotech Inc :
   * ADURO BIOTECH PRESENTS NONCLINICAL AND PHASE 1 HEALTHY VOLUNTEER DATA FOR BION-1301 AT THE 57TH ERA-EDTA VIRTUAL CONGRESS
   * ADURO BIOTECH INC - BION-1301 WAS WELL-TOLERATED, WITH NO SERIOUS ADVERSE EVENTS
   * ADURO BIOTECH INC - PHARMACOKINETICS OF BION-1301 WERE GENERALLY DOSE-PROPORTIONAL WITH AN ESTIMATED HALF-LIFE OF 33 DAYS
   * ADURO BIOTECH INC - BION-1301 DOSE-DEPENDENTLY AND DURABLY REDUCED IGA AND IGM

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;)

BRIEF-Aduro Biotech Presents Nonclinical, Phase 1 Healthy Volunteer Data For BION-1301

推荐文章

一周财经日历 | 超重磅！英伟达、阿里、拼多多财报轮番；美国7月PCE数据来袭

美股机会日报 | 倒计时开始！市场屏息以待鲍威尔讲话；中概股名创优品涨超8%，拼多多涨超4%

一周IPO丨双登股份下周上市，超额认购逾3000倍；佳鑫国际资源火热招股中

AH股追踪丨上证指数一举突破3800点！中芯国际A股飙涨14%，H股涨逾9%

港股异动 | 中兴通讯H股午后持续拉升！盘中涨超13%创历史新高

华盛早报 | 韩国股民疯买港股，外资传大消息，做多中国热情持续攀升；标普“五连阴”！今晚华尔街枕戈以待

美股机会日报 | 关税税率最高15%！美欧敲定框架贸易协议；何小鹏增持310万股，小鹏汽车盘前股价涨超5%

一图看懂 | 哔哩哔哩Q2营收73亿元！上半年手游收入大增68%，经调净利润同比扭亏为盈5.6亿元